XGN
USDExagen Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$11.080
Haut
$11.500
Bas
$10.500
Volume
1.42M
Fondamentaux de l'Entreprise
Capitalisation Boursière
237.0M
Industrie
Diagnostics & Research
Pays
United States
Statistiques de Trading
Volume Moyen
0.23M
Bourse
NGM
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
BTIG Maintains Buy on Exagen, Raises Price Target to $15
BTIG analyst Mark Massaro maintains Exagen with a Buy and raises the price target from $13 to $15.
Exagen Inc. Reports Strong Q3 2025 Results
CARLSBAD, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2025, and recent
Canaccord Genuity Maintains Buy on Exagen, Raises Price Target to $15
Canaccord Genuity analyst Kyle Mikson maintains Exagen with a Buy and raises the price target from $11 to $15.
Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence
CARLSBAD, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing, announced today the acceptance of six abstracts at the 2025 American College of Rheumatology's
BTIG Maintains Buy on Exagen, Raises Price Target to $13
BTIG analyst Mark Massaro maintains Exagen with a Buy and raises the price target from $11 to $13.
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025
CARLSBAD, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended September 30, 2025, before the
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.